Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score48
United States Fiscal year ends December CIK 0001787306 Results filed 4 Nov 2026

What the insiders did Net buying

By person

28 insiders · 407 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Jonathan Silverstein
Director
$21.90M (4)
—
+$21.90M
902,286
0.7179%
$30.96M
—
Frazier Life Sciences VIII, L.P.
10% owner
$13.70M (3)
—
+$13.70M
8,818,574
7.02%
$302.63M
+1,465%
Todd Watanabe
See Remarks
$30.58K (3)
$9.44M (79) scheduled
−$9.41M
920,550
0.7324%
$31.59M
+70.0%
Patrick J Heron
Director
$9.07M (11)
—
+$9.07M
10,602,451
8.44%
$363.84M
+2,073%
Howard G. Welgus
Director
—
$6.80M (75) scheduled
−$6.80M
60,198
0.0479%
$2.07M
−57.0%
Patrick Burnett
EVP, Chief Medical Officer
—
$5.89M (54) scheduled
−$5.89M
116,649
0.0928%
$4.00M
—
Bain Capital Life Sciences Investors, LLC entity
10% owner
$5.00M (1)
—
+$5.00M
3,979,292
3.17%
$136.56M
—
Masaru Matsuda
EVP, Chief Legal Officer
$18.54K (2)
$4.86M (38) scheduled
−$4.84M
111,289
0.0885%
$3.82M
+4,133%
Orbimed Advisors LLC entity
10% owner
$21.90M (4)
$25.45M (8)
−$3.55M
1,317,428
1.05%
$45.21M
—
Bhaskar Chaudhuri
Director
—
$1.83M (12)
−$1.83M
917,807
0.7302%
$31.50M
+6.2%
Larry Todd Edwards
See Remarks
$7.77K (1)
$1.21M (10)
−$1.20M
175,178
0.1394%
$6.01M
+11,998%
David W Osborne
Chief Technical Officer
—
$1.10M (12)
−$1.10M
331,332
0.2636%
$11.37M
+10.8%
Terrie Curran
Director
—
$1.08M (4) scheduled
−$1.08M
23,526
0.0187%
$807.34K
—
Keith R Leonard
Director
—
$997.19K (1) scheduled
−$997.19K
27,901
0.0222%
$957.47K
—
Neha Krishnamohan
Director
—
$939.49K (2) scheduled
−$939.49K
27,901
0.0222%
$957.47K
+2,165%
Sue-Jean Lin
Director
—
$898.54K (2) scheduled
−$898.54K
27,567
0.0219%
$946.01K
+9,089%
John W Smither
Chief Financial Officer
—
$619.52K (13) scheduled
−$619.52K
98,080
0.0780%
$3.37M
+78.4%
Halley E Gilbert
Director
—
$455.44K (1) scheduled
−$455.44K
27,901
0.0222%
$957.47K
—
Scott L Burrows
Chief Financial Officer
—
$298.56K (8)
−$298.56K
59,115
0.0470%
$2.03M
+67.8%
David Joseph Topper
Chief Financial Officer
—
$261.96K (2) scheduled
−$261.96K
182,774
0.1454%
$6.27M
—
Latha Vairavan
SVP Chief Financial Officer
—
$149.77K (7) scheduled
−$149.77K
85,978
0.0684%
$2.95M
+90.6%
Patricia A. Turney
SVP, Operations
—
$116.57K (8)
−$116.57K
62,862
0.0500%
$2.16M
—
Kenneth A. Lock
Chief Commercial Officer
—
$116.22K (8)
−$116.22K
63,429
0.0505%
$2.18M
+1,545%
Matthew Richard Moore
SVP and Chief Business Officer
—
$104.95K (4) scheduled
−$104.95K
145,505
0.1158%
$4.99M
—
Amit Munshi
Director
—
—
—
9,799
0.0078%
$336.27K
+390.0%
Christopher Peetz
Director
—
—
—
4,315
0.0034%
$148.08K
—
Joseph L Turner
Director
—
—
—
4,312
0.0034%
$147.97K
—
Robert A Scott
Director
—
—
—
2,819
0.0022%
$96.74K
—